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Abstract
Background: Clostridium difficile-associated diarrhoea (CDAD) is a frequently occurring
healthcare-associated infection, which is responsible for significant morbidity and mortality
amongst elderly patients in healthcare facilities. Environmental contamination is known to play an
important contributory role in the spread of CDAD and it is suspected that contamination might
be occurring as a result of aerial dissemination of C. difficile spores. However previous studies have
failed to isolate C. difficile from air in hospitals. In an attempt to clarify this issue we undertook a
short controlled pilot study in an elderly care ward with the aim of culturing C. difficile from the air.
Methods: In a survey undertaken during February (two days) 2006 and March (two days) 2007,
air samples were collected using a portable cyclone sampler and surface samples collected using
contact plates in a UK hospital. Sampling took place in a six bedded elderly care bay (Study) during
February 2006 and in March 2007 both the study bay and a four bedded orthopaedic bay (Control).
Particulate material from the air was collected in Ringer's solution, alcohol shocked and plated out
in triplicate onto Brazier's CCEY agar without egg yolk, but supplemented with 5 mg/L of lysozyme.
After incubation, the identity of isolates was confirmed by standard techniques. Ribotyping and
REP-PCR fingerprinting were used to further characterise isolates.
Results: On both days in February 2006, C. difficile was cultured from the air with 23 samples
yielding the bacterium (mean counts 53 – 426 cfu/m3 of air). One representative isolate from each
of these was characterized further. Of the 23 isolates, 22 were ribotype 001 and were
indistinguishable on REP-PCR typing. C. difficile was not cultured from the air or surfaces of either
hospital bay during the two days in March 2007.
Conclusion: This pilot study produced clear evidence of sporadic aerial dissemination of spores
of a clone of C. difficile, a finding which may help to explain why CDAD is so persistent within
hospitals and difficult to eradicate. Although preliminary, the findings reinforce concerns that
current C. difficile control measures may be inadequate and suggest that improved ward ventilation
may help to reduce the spread of CDAD in healthcare facilities.
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Clostridium difficile-associated diarrhoea (CDAD) is a fre-
quently occurring nosocomial infection, which is respon-
sible for significant morbidity and mortality amongst
elderly patients in healthcare facilities. In many countries
the incidence of CDAD seems to be increasing and a
toxin-hyperproducing strain (ribotype 027) is becoming
more common [1,2], despite the fact that many hospitals
have made stringent efforts to control the infection
through isolation of infected patients, improved compli-
ance with handwashing and decontamination of the ward
environment. Several studies have suggested that environ-
mental contamination, particularly of fomites, may play a
role in the spread of CDAD [3-5]. Nosocomial outbreaks
can occur in spatial clusters [6], suggesting that physical
proximity to infected patients might be an important risk
factor for acquisition of C. difficile [7]. This has led to sus-
picion that environmental contamination might be occur-
ring as a result of aerial dissemination of C. difficile spores.
The latter can survive on inanimate surfaces for months,
and inactivating them is problematic since they are rela-
tively resistant to disinfectants. Indeed, sporulation can
actually be enhanced by exposure of cells to some types of
cleaning agent [8]. Processes such as bed making are
known to liberate large numbers of bacteria-carrying par-
ticles into the air [9-11] and it would appear a reasonable
assumption that aerial dissemination of C. difficile vegeta-
tive cells and spores occurs in the same manner. However,
previous studies have failed to isolate C. difficile from air
in hospitals [3,12-14]. In an attempt to clarify this issue
we undertook a short pilot study in an elderly care ward
and orthopaedic ward at a 400-bedded district general
hospital, with the aim of culturing C. difficile from the air.
Methods
The first phase of the study was undertaken on the 21st
(day 1) and 22nd February 2006 (day 2). Sampling took
place in a mechanically ventilated six-bedded bay (Figure
1a) on a 29 bed elderly care ward which had sporadic
cases of CDAD (four confirmed cases in 2005, and a fur-
ther five confirmed cases up to March 2007). Sampling
was repeated on this bay 12 months later on the 1st (day
3) and 2nd (day 4) of March 2007. A naturally ventilated
four-bedded bay (Figure 1b) on a 15 bed orthopaedic
ward, in which no CDAD cases had been reported in the
previous year, was sampled concurrently during this sec-
ond phase.
Ward air was sampled using a portable cyclone air sam-
pler (Burkhard C90M, Burkhard Ltd, UK) located, in the
elderly care ward, outside the entrance to the patient's toi-
let room (positioned on a metal trolley, 870 mm above
floor level at approximately bed height) and, in the ortho-
paedic ward, on the window sill. During each two-day
period, air samples were taken at 30-minute intervals
throughout the day. For each sampling, 250 L of air was
drawn into the device over 15 min. At the end of each day
air samplers were cleaned with Virkon® disinfectant
Floor plan of the study bay (a), with six open bed spaces separated by curtains (dashed lines) and the control bay (b) which contained f ur open bed spaces also separated by curtainsigure 1
Floor plan of the study bay (a), with six open bed spaces separated by curtains (dashed lines) and the control bay (b) which 
contained four open bed spaces also separated by curtains. The 'X' indicates where the air sampling equipment was positioned. 
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ficile spores and vegetative cells. When in use, the devices
were observed closely by the operator to ensure patients
and staff did not touch them or interfere with their opera-
tion in any way.
Particulate matter from the air was collected into 1 mL of
sterile Ringer's solution in Eppendorf tubes. Specimens
were alcohol shocked [15] by mixing with an equal vol-
ume of absolute ethanol. The solution was then vortexed
and held for 1 h at room temperature after which 0.1 mL
aliquots were plated out in triplicate onto Brazier's CCEY
agar (Lab M Ltd, Bury, UK) without egg yolk, but supple-
mented with 5 mg/L of lysozyme (Sigma-Aldrich, Poole,
Dorset, UK) to optimise the recovery of C. difficile [16].
Any alcohol present was allowed to evaporate and the
plates were then incubated at 37°C anaerobically for 48 h.
The identity of isolates with morphology typical of C. dif-
ficile was confirmed using Gram staining and a commer-
cially available latex agglutination test (Oxoid Ltd,
Basingstoke, UK) which detects toxin A. Mean colony
counts per cubic metre of air were calculated.
Environmental samples were taken using Clostridium diff-
icile contact plates (E & O Laboratories, UK). The sites
selected for testing were disinfected at the beginning of
the day and after each sample was taken. In the study
ward, samples were taken from the floor, top of the radia-
tor, top of the ward door, a ventilation extract grille above
bed C (see Figure 1a) and a ventilation extract grille above
the nurses' station. On the control ward, samples were
taken from the floor, the top of the ward door and the
shelf adjacent to the hand-wash sink. Each site was
screened at three set times during the day using two con-
tact plates each time. Plates were incubated under anaero-
bic conditions at 37°C for 48 h.
Ribotyping [17] and repetitive extragenic palindromic
REP-PCR typing [18] were used to compare the related-
ness of selected isolates. C. difficile NCTC 11209 was used
as a control for the DNA extraction and purification proc-
ess. Reference strains of C. difficile ribotypes 001, 002,
010, 014, 027 and 106 were included as standards. Strains
were cultured in Brain Heart Infusion Broth supple-
mented with 0.5% yeast extract and 0.5 mg of haemin,
incubated anaerobically at 37°C for 24 h. Cells from 1.5
mL of culture were pelleted by centrifugation. DNA was
extracted using the GenEluteTM Bacterial Genomic DNA
kit (Sigma-Aldrich).
PCR ribotyping was performed based on a method
described previously [17] using primers 5'-CTGGGGT-
GAAGTCGTAACAAGG-3' and 5'-GCGCCCTTTGTAGCTT-
GACC-3'. A 25 μl reaction mix contained 1× Thermopol II
Buffer (New England Biolabs), 200 mM of each dNTP,
2.25 mM of MgSO4, 50 pmol of each primer (Sigma-
Genosys), 2.5 units of Taq polymerase (New England
Biolabs) and 2.5 μl of DNA template. The reaction mix
was made up to 25 μL using molecular grade water
(Sigma-Aldrich). Thirty-five cycles of amplification were
carried out, consisting of 1 min at 94°C, 1 min at 55°C
and 2 min at 72°C. Amplimers were resolved on a 2%
agarose gel (Invitrogen). After ethidium bromide staining,
banding patterns were compared visually.
REP primers REP1R-I, 5'-IIIICGICGICATCIGGC-3' and
REP2-I, 5'-ICGICTTATCIGGCCTAC-3' were used in a PCR
reaction based on a previously described method for typ-
ing C. difficile [18] with minor modifications. A 25 μL
reaction mix contained 1× Thermopol II Buffer (New Eng-
land Biolabs), 200 μM of each dNTP, 2.5 mM of MgSO4,
25pmol of each primer (Sigma-Genosys), 2 units Taq
polymerase (New England Biolabs), 100 μg/mL bovine
serum albumin (Promega) and DNA template (60 ng).
The reaction mix was made up to 25 μL using molecular
grade water (Sigma-Aldrich). Initial denaturation was 2
min at 95°C and 3 secs at 94°C. Thirty cycles of amplifi-
cation were then carried out, consisting of 30 secs at 92°C,
1 min at 40°C and 2 min at 65°C. The final extension was
for 15 min at 65°C. Amplimers were resolved on a 1.5%
agarose gel. After ethidium bromide staining, banding
patterns were compared visually.
The work described in this paper was originally under-
taken as part of enhanced environmental surveillance as
contained in Harrogate Health Care Trust's Infection Con-
trol Annual Plan ratified by the Trust Board. However,
when it became clear that the surveillance yielded results
of wider interest which might merit publication, the
Trust's Research Governance Committee approved a
request to submit.
Results
The results of the first phase of air sampling are presented
in Figures 2 and 3. From these it can be seen that on both
days C. difficile was cultured from the air of the elderly care
bay, with counts of 53 – 426 cfu/m3 of air, indicating that
substantial numbers of C. difficile-spores were liberated
into the ward air throughout this period. The limit of
detection for the method was 27 cfu/m3 – this being the
count that would have been recorded if a single colony
was observed amongst the triplicate agar plates (1 colony
arising from 0.3 ml of the alcohol shock solution = 6.67
cfu from the 250 L of air sampled, which in turn approxi-
mates to 27 per m3).
It should be noted that no sample was collected at 09.45
on day 1. Twenty-three air samples in total yielded C. dif-
ficile andone representative isolate (coded CAS 1 to 23)
from each of these was ribotyped. Of the 23 isolates, 22Page 3 of 6
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same REP-PCR profile, but the pattern was different to
that of the ribotype 001 reference strain (data not shown).
The ribotype of the remaining isolate did not match any
of the reference strains.
During the phase 1 survey, C. difficile was not isolated
from the surfaces sampled in the elderly care ward. During
the second phase of sampling, C. difficile was not cultured
from air samples or isolated from environmental sites in
both the study and control bays.
Discussion
Earlier researchers, possibly because of sub-optimal recov-
ery methods, such as the use of settle plates [3,12-14],
failed in attempts to culture C. difficile from the air of hos-
pital wards thus lending weight to the generally held opin-
ion that airborne transmission of the bacterium is
unimportant [12,19]. However, there is increasing evi-
dence that airborne dissemination may play a role in the
spread of C. difficile within the clinical environment. For
example, air vents and high horizontal surfaces have been
noted to be contaminated with C. difficile, [5,20] suggest-
ing dissemination via the air. Furthermore, other studies
have found C. difficile on patients' bedding [12-14]. As
bed making is known to liberate large numbers of bacte-
ria-carrying particles into the air [9-11], these observa-
tions would suggest that C. difficile may be disseminated
into the air by this route following these activities. We
were able to isolate C. difficile spores from the air on two
separate days, and to our best knowledge, this is the first
report to suggest aerial dissemination of this bacterium
within a hospital.
The cyclone air sampler was located outside the toilet and
it is possible that many of the isolates recovered from the
air originated from this area. Previous work [13,14] has
found surfaces within bathrooms and toilets to be among
the most contaminated areas within hospitals, which is
not surprising given that C. difficile colonises the colon.
However, during the two sampling days no one was
observed using the toilet as many of the patients were bed-
bound. Notwithstanding this, the patient in bed D (clos-
est to the air sampler; Figure 1) did have diarrhoea during
the sampling period and used a commode on several
occasions during day 2. A stool sample was negative for C.
difficile toxin A (at tha t time the laboratory did not test for
toxin B production) but this does not rule out the possi-
bility of asymptomatic gut carriage with the bacterium
[21-24]. Indeed, asymptomatic carriers are recognised as a
potential cause of environmental contamination [21,22].
PCR ribotype profiles of C. difficile isolates CAS 1 to 10 (lanes 1–10) ob ain d from air samples, Lane R = ribotype 001 ref-erence strainFigu  4
PCR ribotype profiles of C. difficile isolates CAS 1 to 10 (lanes 
1–10) obtained from air samples, Lane R = ribotype 001 ref-
erence strain. Lane M = O'GeneRuler™ DNA ladder (10 kbp 
– 100 bp).
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Mean C. difficile counts in the air of the study ward on day 1Figure 2
Mean C. difficile counts in the air of the study ward on day 1. 
(NB. a value of zero denotes 'below the detection limit of 27 
cfu/m3'; NDC denotes 'no data collection').
0
50
100
150
200
250
300
350
400
450
7.45 8.15 8.45 9.15 9.45 10.15 10.45 11.15 11.45 12.15 12.45 13.15 13.45 14.15 14.45 15.15
Time of Day (Hours)
Av
er
ag
e 
co
lo
ny
 
co
un
t o
f C
.
 
di
ffi
ci
le
 
(cf
u
/m3
 
ai
r)
NDC 
Mean C. difficile counts in the air of the study ward on day 2 (NB. a value of zero de otes 'bel w the detection limit of27cfu/m3'Figure 3
Mean C. difficile counts in the air of the study ward on day 2 
(NB. a value of zero denotes 'below the detection limit of 
27cfu/m3'.
 
 
 
 
Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
0
50
100
150
200
250
300
350
400
450
7.45 8.15 8.45 9.15 9.45 10.15 10.45
 
11.15 11.45 12.15 12.45 13.15 13.45 14.15 14.45 15.15
Time of Day (Hours)
Av
er
ag
e 
co
lo
ny
 
co
un
t o
f C
.
 
di
ffi
ci
le
 
(cf
u/
m3
 
ai
r)Page 4 of 6
(page number not for citation purposes)
BMC Infectious Diseases 2008, 8:7 http://www.biomedcentral.com/1471-2334/8/7Before the two sampling days in February 2006, the last
time a patient with confirmed CDAD was on the ward was
seven weeks earlier and the next case was four weeks later.
This shows that C. difficile can be isolated from the air in
the absence of a confirmed case/outbreak of CDAD.
The results of the ribo- and REP-PCR-typing indicate that
all but one of the isolates found in the air were clonal and
may have come from the same source. Earlier studies have
shown that some strains of C. difficile are more likely to
contaminate the local environment than others [5,25]
and the 001 ribotype cultured in this study is currently the
most common strain of C. difficile in the UK.
Very small aerosol particles can remain airborne for long
periods, for example, a 2 μm diameter particle will take
4.2 hours to fall 2 m in a still room [26]. Spores of C. dif-
ficile are of this size range [27] and may thus become
widely distributed around the clinical environment. Aer-
ial dissemination of desiccation-tolerant microorganisms
such as Acinetobacter is also known to result in widespread
environmental contamination [28,29].
Our data give an interesting insight into the physical
nature of the C. difficile aerosolization and dispersal
within the ward. Aerosol particles can be removed from
room air by two principal mechanisms, gravitational dep-
osition and extraction via exhaust ventilation. The resi-
dence time of true airborne particles in a well-ventilated
ward space is generally ≤ 30 min, depending on the venti-
lation rate. Therefore, in such a space most of the airborne
particles will be purged from the air within 30 min of any
aerosol liberation event. From Figures 2 and 3, it can be
seen that, despite some significant fluctuations, large
numbers of particles were found in the air at almost all of
the sampling points suggesting that numerous C. difficile
aerosolization events occurred throughout the sampling
period and also that the cyclone sampler was located close
to the C. difficile dissemination source. It also indicates
that during this period the ventilation system was unable
to purge the ward air of C. difficile-bearing particles. Con-
tinuous observation of the device ensured that no inad-
vertent direct contamination (e.g. from staff/patient
hands or contact with other equipment) occurred during
the sampling period.
Although the study reported here was only a short pilot
study, it produced evidence of aerial dissemination of C.
difficile, a phenomenon which may, at least in part,
explain why CDAD is so persistent within hospitals and
difficult to eradicate. It also demonstrates the transient
nature of the airborne route of dissemination, since on
both sampling days in phase one there were periods
where the spore count per m3 of air was below the limit of
detection. This has consequences for scheduling of air
sampling in future studies of aerial dissemination of C.
difficile.
It is surprising that no environmental specimens yielded
C difficile, even on days when the bacterium was cultured
from the air. This may be because we relied on 65 mm
diameter contact plates. Sampling of larger areas using a
moistened swab may have resulted in a greater yield of C.
difficile [30]. Timing of sampling may also be important as
sampling after ward cleaning may influence the likeli-
hood of recovering the bacterium [30]. Furthermore, the
inclusion of an agent, such as lysozyme which encourages
germination of spores [16] or extending the time of incu-
bation of cultures might have increased recovery. These
issues will be addressed in future investigations.
Conclusion
The study produced clear evidence of sporadic aerial dis-
semination of spores of a clone of C. difficile, a finding
which may help to explain why CDAD is so persistent
within hospitals and difficult to eradicate. As such, our
report is timely because it coincides with concerns that
current C. difficile control measures are failing to halt the
spread of CDAD. Hopefully, it will encourage others to
undertake aerobiological sampling in their own hospitals,
so that a proper evaluation of the extent to which C. diffi-
cile is being disseminated via the air can be made. If air-
borne dissemination is a contributory factor to
environmental contamination, then the use of negatively-
pressurized isolation rooms and improved ward ventila-
tion systems may help to reduce the spread of CDAD in
healthcare facilities and these interventions warrant
urgent evaluation.
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